Followers | 28 |
Posts | 3448 |
Boards Moderated | 0 |
Alias Born | 06/30/2012 |
Wednesday, May 28, 2014 7:56:48 PM
I know I bash, but that is because like you my investment is about worthless here. I would like to share something with you and the mods can feel free to sticky if they like. It is my own due diligence. I received this email from Dr. Sharp at NMU today, so take it for what its worth, and I wish lots of hope for all of us here, my name removed from heading.
Hi ,
To answer your question. I am an independent investigator working with MIT. I do have a system in my lab, and we are in the initial stages of working on a Staphylococcus Identifier as the press release stated. However this is NOT a phase I clinical trial. Hopefully once we develop the identifier and test it extensively with known samples, then we can move on to more advanced studies with clinical specimens. We are not at that point yet.
-Josh
Josh Sharp, Ph.D.
Assistant Professor of Biology
Northern Michigan University
New Science Facility
1401 Presque Isle Ave.
Marquette, Michigan 49855
Phone: 906-227-2380
Email: jsharp@nmu.edu
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM